Last edition
News about Global Pharma
IDT Biologika Welcomes Federico Pollano as New Chief Commercial Officer
Federico Pollano has extensive experience in management positions at global CDMOs in the pharmaceutical and biotechnology industry.
Global Pharma | 18/01/2025 | By Aishwarya | 540
FDA Approves First Mesenchymal Stromal Cell Therapy 'RYONCIL'
The Food and Drug Administration (FDA) approved the first mesenchymal stromal cell (MSC) therapy, RYONCIL®, indicated for steroid-refractory acute graft-versus-host disease (SR-aGVHD) in children two months and older.
Global Pharma | 17/01/2025 | By Manvi | 596
Samsung Biologics Highlights 2025 Outlook at J.P. Morgan Healthcare Conference
Samsung Biologics announced its latest business achievements and 2025 outlook at the 43rd J.P. Morgan Healthcare Conference, which was held in San Francisco between January 13-16.
Global Pharma | 17/01/2025 | By Manvi | 809
Alembic Pharmaceuticals Announces USFDA Final Approval for Brexpiprazole Tablets
Alembic Pharmaceuticals has received USFDA final approval for its ANDA of Brexpiprazole Tablets in multiple strengths, a therapeutic equivalent to Otsuka's Rexulti, used for major depressive disorder and schizophrenia.
Global Pharma | 17/01/2025 | By Manvi | 270
Innovent and ASK Pharma Announce NMPA Approval of Limertinib for Lung Cancer
Innovent Biologics and Jiangsu Aosaikang Pharmaceutical announced that China's NMPA has approved the New Drug Application (NDA) of limertinib for treating adult patients with locally advanced or metastatic EGFR T790M-mutated non-small cell lung cancer (NSCLC).
Global Pharma | 17/01/2025 | By Manvi | 291
Avicanna and Vectura Fertin Pharma are collaborating to establish a joint Scientific and Medical Affairs Committee focused on improving the understanding of medical cannabis access and applications in Canada.
Global Pharma | 17/01/2025 | By Abha | 468
Biofidelity and CellCarta Announce Partnership to Enhance NSCLC Clinical Trials with Aspyre Lung
Aspyre Lung simplifies the detection of established non-small cell lung cancer (NSCLC) biomarkers by analysing both DNA and RNA from tissue and blood using a streamlined four-step workflow.
Global Pharma | 17/01/2025 | By Abha | 352
Sun Pharma to Acquire Canada-based Clinical-stage Biotechnology Company Antibe Therapeutics
Sun Pharmaceutical Industries Ltd. is set to acquire Canada-based Antibe Therapeutics, a clinical-stage biotech firm focused on pain and inflammation drugs, through its subsidiary TARO Pharmaceuticals. The indicative period for completion of the acquisition is before March 7, 2025.
Global Pharma | 16/01/2025 | By Manvi | 796
ErlySign Secures INR 16 Crore in Pre-Series A Funding from Investor Ashish Kacholia
The investment, advised by DerivativeSaint—a boutique private equity and venture capital advisory firm—marks a pivotal moment for CURO Biosciences.
Global Pharma | 16/01/2025 | By Aishwarya | 568
Alembic Pharmaceuticals Gets USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Depakote Sprinkle Capsules, 125 mg, of AbbVie Inc.
Global Pharma | 16/01/2025 | By Aishwarya | 398
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy